Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in ...

This important study describes a combination of in vitro and in vivo results implicating Dyrk1a in the regulation of mTOR. Strengths include the combination of cell and whole-animal (Drosophila) based ...

B cells are a type of white blood cell. They make antibodies -- proteins that fight viruses and bacteria. B cells normally can’t cross from your blood into your brain or spinal cord. If you have ...

The event will raise funds to further tuberous sclerosis complex (TSC) research and expand support programs for individuals and families affected by the disease. Formed in 1974 by four mothers in ...

The event will raise funds to further tuberous sclerosis complex (TSC) research and expand support programs for individuals and families affected by the disease. Formed in 1974 by four mothers ...

We know so much more about multiple sclerosis (MS) than we used to. But one important theme is that we’ve become much better at treating the relapsing form of this disease and changing its ...

Over the past few decades, the quality of life and life expectancy for people with multiple sclerosis (MS) has improved significantly. MS is a neurological condition that affects nearly 1 million ...

The randomized clinical trial compared the effectiveness of modafinil, a wake-promoting medication used to treat sleepiness in people with sleep disorders, and cognitive behavioral therapy, or CBT ...

Developed by neurologist John Kurtzke to replace his Disability Status Scale (DSS), it is a way of measuring disability and progression in multiple sclerosis. The EDSS is also used widely in clinical ...

Objectives To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods An ...